WEBULL
WebtradeDownload

Is Eurazeo (ENXTPA:RF) Undervalued After Stronger Half Year Earnings?

Simply Wall St · 1d ago

Eurazeo earnings event and recent share performance

Eurazeo (ENXTPA:RF) reported half year 2026 results on 3 August, with sales of €211.44 million and a net loss of €6.34 million, compared with a much larger loss a year earlier.

For investors, this earnings update offers fresh context for a stock that is up around 0.9% on the day of the last close, about 5.4% over the past week and roughly 30% over the past month.

See our latest analysis for Eurazeo.

Eurazeo's latest earnings update appears to be supporting a strong run of momentum, with a 30.1% 1 month share price return adding to a 12.8% 3 year total shareholder return, while the 5 year total shareholder return remains negative.

If Eurazeo's recent rebound has you reviewing your watchlist, this can be a good moment to broaden your search with 101 top founder-led companies

After a 30% move in a month and an improved loss profile, Eurazeo now sits at a very different starting point for new money. Is it worth accepting today’s price, or waiting for a cleaner entry once valuation is clearer?

Most Popular Narrative: 26% Undervalued

The most followed narrative on Eurazeo currently points to a fair value of about €72.50 per share, compared with the recent close at €53.40. That gap is built on a detailed view of how its asset management and investment activities could translate into higher earnings over time.

Eurazeo's asset management segment is experiencing dynamic growth, with fundraising up 23% and management fees from third parties increasing by 14%. This suggests potential future revenue growth due to higher fee-paying assets under management (AUM).

Read the complete narrative.

Curious what kind of revenue growth, margin profile and exit activity analysts are baking into this story. The narrative leans on ambitious earnings and a future earnings multiple that many investors usually associate with more mature compounders. Want to see exactly which assumptions have to line up for that fair value to hold.

Result: Fair Value of €72.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Eurazeo's story could change quickly if legacy assets require further write downs, or if exit markets slow and delay planned asset rotations and cash returns.

Find out about the key risks to this Eurazeo narrative.

Another view on Eurazeo’s valuation

The SWS DCF model suggests Eurazeo is trading around 26.6% below an estimated fair value of about €72.80 per share, which points to an undervalued setup. That sits against a relatively high P/S ratio flagged in the checks. Which signal do you put more weight on?

Look into how the SWS DCF model arrives at its fair value.

RF Discounted Cash Flow as at Aug 2026
RF Discounted Cash Flow as at Aug 2026

Next Steps

Reading mixed signals on Eurazeo after this earnings update and valuation work. Take a closer look at the underlying data and form your own view, then weigh up the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Eurazeo?

If Eurazeo has sharpened your focus, do not stop here. Use this momentum to line up other opportunities that could strengthen and diversify your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.